trending Market Intelligence /marketintelligence/en/news-insights/trending/0ctQtT0wbg0DeoTiQvp2KA2 content esgSubNav
In This List

InVivo Therapeutics CEO resigns

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


InVivo Therapeutics CEO resigns

InVivo Therapeutics Holdings Corp. CEO Mark Perrin is resigning, to be replaced by Richard Toselli on an acting basis.

Ann Merrifield will replace Perrin as the chair of the company's board. Merrifield was previously the company's lead director.

Toselli currently serves as InVivo's chief medical officer and he will continue to do so.